News

Learn how and why East Indian Sandalwood Oil (EISO) is making international headlines as a unique, non-substitutable botanical drug candidate.

ViroXis Corporation Initiates Phase II Clinical Trial of Novel Botanical Topical Treatment for HPV Skin Warts: Announces Expanded Board of Directors and Advisors

Posted on

(SAN ANTONIO, TX – December 4, 2012): ViroXis Corporation today announced that it has enrolled its first patient in its Phase II study for the topical treatment of Human Papilloma Virus (HPV) common skin warts using an East Indian Sandalwood oil (EISO) derived drug candidate. ViroXis’ patented, EISO-derived product is being developed in accordance with the US Food and Drug […]Read More ViroXis Corporation Initiates Phase II Clinical Trial of Novel Botanical Topical Treatment for HPV Skin Warts: Announces Expanded Board of Directors and Advisors